Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov;31(6):485-93.
doi: 10.6515/acs20141201e.

Early Elevated B-Type Natriuretic Peptide Levels are Associated with Cardiac Dysfunction and Poor Clinical Outcome in Pediatric Septic Patients

Affiliations

Early Elevated B-Type Natriuretic Peptide Levels are Associated with Cardiac Dysfunction and Poor Clinical Outcome in Pediatric Septic Patients

Jiunn-Ren Wu et al. Acta Cardiol Sin. 2015 Nov.

Abstract

Background: To determine the B-type natriuretic peptide (BNP) level in pediatric septic patients, and to investigate its association with cardiovascular dysfunction and clinical outcome.

Methods: Pediatric patients with sepsis or septic shock were prospectively enrolled in our pediatric intensive care unit (PICU). On day 1 of admission, plasma BNP levels were measured at the time-point of echocardiography. Myocardial dysfunction was defined as left ventricular fractional shortening (FS) < 30%. Inotropic support was quantified by inotropic scores and disease severity was assessed by Pediatric Risk of Mortality (PRISM) III scores. Therafter, associations between BNP levels and clinical parameters were analyzed.

Results: There were 94 patients (mean: 5.6 yr, range: 2 mo-17 yr) that were consecutively enrolled in this study. The median BNP level was 127 pg/ml (range: 5 to 4950 pg/ml). BNP levels were correlated with PRISM III (rho = 0.36, p = 0.001) and C-reactive protein level (r = 0.39, p = 0.001). The median BNP levels were not only higher in patients with septic shock (n = 34) than those with sepsis (n = 58) (213 vs. 54 pg/ml, p = 0.0004), but also higher in patients with myocardial dysfunction (n = 18) than those with preserved myocardial function (n = 66) (765 vs. 65 pg/ml, p < 0.001). We also found that BNP levels correlated negatively with FS (r = -0.56, p < 0.001) and positively with inotropic scores (r = 0.34, p = 0.04). Most importantly, the median BNP levels were higher in non-survivors (n = 13) than survivors (n = 81) (367 vs. 106 pg/ml, p = 0.003).

Conclusions: BNP levels are elevated in pediatric septic patients early in the disease course, and increased levels are associated with cardiovascular dysfunction and worse clinical outcome.

Key words: B-type natriuretic peptide; Cardiac function; Pediatric; Sepsis; Septic shock.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Scatter plots showing the relationship between BNP levels and PRISM III scores (A) and CRP (B). Higher BNP levels were associated with higher PRISM III and CRP. Abbreviations are in Table 1; BNP, B-type natriuretic peptide.
Figure 2
Figure 2
Box plots showing the relationship of BNP to PICU mortality. BNP levels were higher in non-survivors. Boxes show the interquartile range with the midline indicating the median level. I-bars represent the highest and lowest values. Abbreviations are in Table 1; BNP, B-type natriuretic peptide.
Figure 3
Figure 3
Box plots showing the relationship of BNP to presence of shock (A) and cardiac dysfunction (B). BNP levels were higher in patients with septic shock, and those with cardiac dysfunction. Boxes show the interquartile range with the midline indicating the median level. I-bars represent the highest and lowest values. BNP, B-type natriuretic peptide.
Figure 4
Figure 4
Scatter plots showing the relationship between FS (A) and inotropic scores (B). Higher BNP levels were associated with lower FS and higher inotropic scores. N = 36 in B because inotropes were only administered in patients with septic shock. BNP, B-type natriuretic peptide; FS, fractional shortening.

Similar articles

Cited by

References

    1. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101:1644–1655. - PubMed
    1. Kutko MC, Calarco MP, Flaherty MB, et al. Mortality rates in pediatric septic shock with and without multiple organ system failure. Pediatr Crit Care Med. 2003;4:333–337. - PubMed
    1. Parrillo JE, Parker MM, Natanson C, et al. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med. 1990;113:227–242. - PubMed
    1. Hsu JH, Wu JR, Dai ZK, et al. Cardiac Arrhythmias - New Considerations, 1st ed. Croatia, InTech: In: Breijo-Marquez FR, Ed.; 2012. Approach to ventricular arrhythmias in the pediatric intensive care unit; p. DOI: 10.5772/25402.
    1. Krishnagopalan S, Kumar A, Parrillo JE, Kumar A. Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care. 2002;8:376–388. - PubMed

LinkOut - more resources